CORC

在结果中检索

CORC

浏览/检索结果: 共18条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
The deep learning model combining CT image and clinicopathological information for predicting ALK fusion status and response to ALK-TKI therapy in non-small cell lung cancer patients 期刊论文
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020
作者:  Song, Zhengbo;  Liu, Tianchi;  Shi, Lei;  Yu, Zongyang;  Shen, Qing
收藏  |  浏览/下载：18/0  |  提交时间：2020/10/26
CT-Based Radiomic Signature as a Prognostic Factor in Stage IV ALK-Positive Non-small-cell Lung Cancer Treated With TKI Crizotinib: A Proof-of-Concept Study 期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10, 页码: 9
作者:  Li, Hailin;  Zhang, Rui;  Wang, Siwen;  Fang, Mengjie;  Zhu, Yongbei
收藏  |  浏览/下载：48/0  |  提交时间：2020/04/07
Chinese perspectives on clinical efficacy and safety of alectinib in patients with ALK-positive advanced non-small cell lung cancer 期刊论文
ONCOTARGETS AND THERAPY, 2019, 卷号: 12
作者:  Yu, Hui;  Sun, Si;  Hu, Xingjiang;  Xia, Jinjing;  Wang, Jialei
收藏  |  浏览/下载：25/0  |  提交时间：2019/12/05
ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib: A case report 期刊论文
ONCOLOGY LETTERS, 2019, 卷号: 17, 期号: 2
作者:  Xu, Xiaojing;  Li, Hong;  Peng, Ke;  Yu, Yiyi;  Chen, Lingli
收藏  |  浏览/下载：22/0  |  提交时间：2019/12/05
Treatment Optimization for Brain Metastasis from Anaplastic Lymphoma Kinase Rearrangement Non-Small-Cell Lung Cancer 期刊论文
2019, 页码: 1-8
作者:  Wang Wenhui;  Sun Xin;  Hui Zhouguang
收藏  |  浏览/下载：27/0  |  提交时间：2020/01/03
Treatment duration as a surrogate endpoint to evaluate the efficacy of crizotinib in sequential therapy for patients with advanced ALK-positive non-small cell lung cancer: A retrospective, real-world study 期刊论文
2019, 卷号: 8, 期号: 13, 页码: 5823-5830
作者:  Yang Guangjian;  Ma Di;  Xu Haiyan;  Yang Lu;  Li Junling
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Design, synthesis and pharmacological evaluation of ALK and Hsp90 dual inhibitors bearing resorcinol and 2,4-diaminopyrimidine motifs 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 152, 页码: 76-86
作者:  Geng, Kaijun;  Liu, Hongchun;  Song, Zilan;  Zhang, Chi;  Zhang, Minmin
收藏  |  浏览/下载：177/0  |  提交时间：2019/01/08
Discovery of 2,4-diarylaminopyrimidines bearing a resorcinol motif as novel ALK inhibitors to overcome the G1202R resistant mutation 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 144, 页码: 386-397
作者:  Geng, Kaijun;  Xia, Zongjun;  Ji, Yinchun;  Zhang, Ruisi (Ruthy);  Sun, Deqiao
收藏  |  浏览/下载：155/0  |  提交时间：2019/01/08
Pharmacologic characterization of CT-711, a novel dual inhibitor of ALK and c-Met 期刊论文
AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 卷号: 8, 期号: 8, 页码: 1541-1550
作者:  Wang, Lei;  Gao, Mingzhao;  Tong, Mengya;  Xie, Chengying;  He, Ye
收藏  |  浏览/下载：151/0  |  提交时间：2019/01/08
Mutation L1196M-induced conformational changes and the drug resistant mechanism of anaplastic lymphoma kinase studied by free energy perturbation and umbrella sampling 期刊论文
PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2017, 卷号: 19, 期号: 44, 页码: 30239-30248
作者:  Chen, Jianzhong;  Wang, Jinan;  Zhu, Weiliang
收藏  |  浏览/下载：17/0  |  提交时间：2019/01/08

©版权所有 ©2017 CSpace - Powered by CSpace